1. 218P A symbiotic relationship between persistent and emerging resistant oligo-clones dictates resistance to immunotherapy in pancreatic cancer. (December 2022) Authors: Ragulan, C.; Ikami, Y.; Desai, K.; Varun Lawrence, P.; Mohammed Musheer Aalam, S.; Kannan, N.; Sadanandam, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 37P Synthetic tumour-infiltrating interleukin (IL)-12 for targeted and tolerable immunotherapy reduces metastasis in pancreatic cancer. (December 2022) Authors: Herpels, M.; Mansurov, A.; Ragulan, C.; Hussain, A.; Ishihara, J.; Sadanandam, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1207: Exploring molecular subtype as a biomarker of radiation response in muscle-invasive bladder cancer. (November 2020) Authors: Tan, M.; Nyamundanda, G.; Fontana, E.; Hazell, S.; Ragulan, C.; Jones, K.; Abah, B.; Jacobs, T.; Bowes, J.; Sadanandam, A.; Huddart, R. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗